S100A14 Promotes the Growth and Metastasis of Hepatocellular Carcinoma |
Zhao, Fu-Tao
(Department of Infectious Diseases, Wuhan General Hospital, Guangzhou Military Area Command)
Jia, Zhan-Sheng (The State Key Discipline and Center for Infectious Diseases, Tangdu Hospital Affiliated to the Fourth Military Medical University) Yang, Qun (Department of Infectious Diseases, Wuhan General Hospital, Guangzhou Military Area Command) Song, Le (Department of Infectious Diseases, Wuhan General Hospital, Guangzhou Military Area Command) Jiang, Xiao-Jing (Department of Infectious Diseases, Wuhan General Hospital, Guangzhou Military Area Command) |
1 | Boye K, Maelandsmo GM (2010). S100A4 and metastasis: a small actor playing many roles. Am J Pathol, 176, 528-35. DOI ScienceOn |
2 | Bulk E, Sargin B, Krug U, et al (2009). S100A2 induces metastasis in non-small cell lung cancer. Clin Cancer Res, 15, 22-9. DOI ScienceOn |
3 | Chen H, Yu D, Luo A, et al (2009). Functional role of S100A14 genetic variants and their association with esophageal squamous cell carcinoma. Cancer Res, 69, 3451-7. DOI ScienceOn |
4 | Chen H, Yuan Y, Zhang C, et al (2012). Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation. J Biol Chem, 287, 109-19. |
5 | El-Serag HB (2012). Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142, 1264-73. DOI ScienceOn |
6 | Gao J, Xie L, Yang WS, et al (2012). Risk factors of hepatocellular carcinoma--current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52. 과학기술학회마을 DOI ScienceOn |
7 | Hiratsuka S, Watanabe A, Aburatani H, Maru Y (2006). Tumor mediated up-regulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol, 8, 1369-75. DOI ScienceOn |
8 | Jin Q, Chen H, Luo A, Ding F, Liu Z (2011). S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE). PLoS One, 6, e19375. DOI ScienceOn |
9 | Li P, Lin Y, Zhang Y, Zhu Z, Huo K (2013). SSX2IP promotes metastasis and chemotherapeutic resistance of hepatocellular carcinoma. J Transl Med, 11, 52. DOI |
10 | Li W, Tan D, Zhang Z, Liang JJ, Brown RE (2008). Activation of Akt-mTOR- p70S6K pathway in angiogenesis in hepatocellular carcinoma. Oncol Rep, 20, 713-9. |
11 | Lukanidin E, Sleeman JP (2012). Building the niche: the role of the S100 proteins in metastatic growth. Semin Cancer Biol, 22, 216-25. DOI ScienceOn |
12 | McClune AC, Tong MJ (2010). Chronic hepatitis B and hepatocellular carcinoma. Clin Liver Dis, 14, 461-76. DOI ScienceOn |
13 | Nordenstedt H, White DL, El-Serag HB (2010). The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis, 42, S206-14. DOI ScienceOn |
14 | Sapkota D, Costea DE, Blø M, et al (2012). S100A14 inhibits proliferation of oral carcinoma derived cells through G1-arrest. Oral Oncol, 48, 219-25. DOI ScienceOn |
15 | Tao YM, Huang JL, Zeng S, et al (2013). BTB/POZ domaincontaining protein 7: Epithelial-mesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma. Hepatology, 57, 2326-37. DOI ScienceOn |
16 | Wang HY, Zhang JY, Cui JT, et al (2010). Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery. Oncol Rep, 23, 45-52. |
17 | Xue TC, Chen RX, Han D, et al (2012). Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential. Exp Ther Med, 3, 117-23. |
18 | Yang Y, Nagano H, Ota H, et al (2007). Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery, 141, 196-202. DOI ScienceOn |
19 | Zhou L, Liu J, Luo F (2006). Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol, 12, 1175-81. |
![]() |